FDA Warns of Itching Risks with Popular Allergy Medications
Seasonal allergies are triggered by pollen and blooming flowers and other plants. Allergy symptoms include runny noses, itchy eyes, sneezing, and sometimes coughing. Patients have been prescribed medications, and in some cases, take over-the-counter allergy medication. Recently, the U.S. Food and Drug Administration (FDA) warned the public that when patients stop long-term use of Zyrtec or Xyzal, oral allergy medications, may experience rare but severe itching. If you or your child suffered severe adverse effects from Zyrtec, Xyzal or another allergy medication, you should call the experienced Chicago-based product liability attorneys of the Moll Law Firm about whether you have a case against the manufacturer or others in the chain of distribution.
Call Moll Law Group About Your Claim
Cetirizine (Zyrtec) and levocetirizine (Xyzal) are antihistamines, which are mobilized to stop histamines released during people’s allergic responses to seasonal allergens like pollen and grass. The former was approved in 1995 and became an over-the-counter medicine in 2008. The latter was approved for prescriptions in 2007 and was made an over-the-counter drug in 2017.
The American College of Allergy, Asthma and Immunology has cited information from the Centers for Disease Control and Prevention (CDC) that indicates about 1 out of 3 adults and 1 out of 4 children in the United States have reported their food allergy, eczema, or seasonal allergy. Over 100 million people in the country have stated they have allergy symptoms. The FDA’s public warning noted that people purchased over 80 million packs of popular allergy medications in 2022.
Illinois Injury and Mass Tort Lawyer Blog





On May 1, 2025, SharkNinja Foodi OP Series Multi-Function Pressure Cookers were
Two Alzheimer’s drugs Leqembi and Kisunla were approved by the FDA to treat mild dementia or a pre-Alzheimer’s condition called mild cognitive impairment. Data had suggested that Leqembi could slow cognitive decline in Alzheimer’s patients by five months over a period of 18 months for patients who had only mild symptoms. Two thousand volunteers had agreed to test Leqembi in clinical studies. However, it turns out these drugs may also increase the risk for brain bleeds and swelling in patients with certain genetic profiles—and patients may not have been given
On February 20, 2025, Super 73
Recently, the Food and Drug Administration issued a
The Triumph TF250-X Off-Road Motorcycle, which is imported by Triumph Motorcycles America, has been
Recently, after a three-week trial, jurors in a state court
Recently, ICU Medical, Inc.
4, the Chicago-based company Riverside Natural Foods
A multistate outbreak of listeria monocytogenes has impacted frozen supplement shakes made by Prairie Farms. As of February 21, 2025, 38 people have been infected by the outbreak across 21 states. On February 22, 2025, Lyons Magnus LLC